Cardiometabolic syndrome

Cardiometabolic syndrome (CMS) is a combination of metabolic dysfunctions mainly characterized by insulin resistance, impaired glucose tolerance, dyslipidemia, hypertension, and central adiposity. CMS is now recognized as a disease entity by the World Health Organization and the American Society of Endocrinology.

  • A large waist. Carrying excess fat around your waist, in particular, is a large risk factor. ...
  • A high triglyceride level. ...
  • Reduced HDL or “good” cholesterol. ...
  • Increased blood pressure. ...
  • Elevated fasting blood sugar.

Related Conference of Cardiometabolic syndrome

March 11-12, 2024

13th World Heart Congress

Paris, France
May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Cardiometabolic syndrome Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in